The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

She grew weaker and decided to visit a nearby clinic to get help after returning home from a family trip. Turns out Pulane ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

"We are honored to continue this important work with support from the Gates Foundation," said Dr. Jin Li, Chairman of the ...

Early clinical trial results show that the new antibiotic sorfequiline, used in the SPaL regimen, demonstrated stronger ...

A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...